Overexpression of a modified protein from amaranth seed in Escherichia coli and effect of environmental conditions on the protein expression
► We inserted 4 VY and 1 IPP antihypertensive peptides in the amarantin acidic subunit. ► Modified protein was overexpressed in Escherichia coli in a fermentor finding the best factors. ► The temperature, agitation speed and oxygen had effect on the yield of the protein. ► Modified protein is ten ti...
Saved in:
Published in | Journal of biotechnology Vol. 158; no. 1-2; pp. 59 - 67 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
31.03.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ► We inserted 4 VY and 1 IPP antihypertensive peptides in the amarantin acidic subunit. ► Modified protein was overexpressed in Escherichia coli in a fermentor finding the best factors. ► The temperature, agitation speed and oxygen had effect on the yield of the protein. ► Modified protein is ten times more active than the non-modified sample.
Amaranth seeds are considered as an excellent complementary source of food protein due to their balanced amino acid composition. Amarantin acidic subunit has the potential as a functional and nutraceutical protein, and it is structurally a good candidate for modification. The aim of this work was to improve its functionality, then the primary structure was modified into the third variable region of 11S globulins, by inserting antihypertensive peptides: four Val-Tyr in tandem and Arg-Ile-Pro-Pro in the C-terminal region. Modified protein was expressed in Escherichia coli Origami (DE3) and was purified. The culture conditions, including the culture media, temperature, agitation speed and air flow were tested in order to obtain an increased expression levels of the modified protein. A 23 factorial design was used for evaluate the effect of environmental conditions on modified protein production. The results indicated that the yield of modified protein could be increased by up 3-fold in bioreactor as compared with flask. In addition, the temperature, the agitation speed and the oxygen were significant factors on the expression of the antihypertensive protein. The maximum production was 99mg protein-L−1. The hydrolyzed protein showed a high inhibitory activity of the angiotensin converting enzyme (IC50=0.047mgmL−1). |
---|---|
AbstractList | Amaranth seeds are considered as an excellent complementary source of food protein due to their balanced amino acid composition. Amarantin acidic subunit has the potential as a functional and nutraceutical protein, and it is structurally a good candidate for modification. The aim of this work was to improve its functionality, then the primary structure was modified into the third variable region of 11S globulins, by inserting antihypertensive peptides: four Val-Tyr in tandem and Arg-Ile-Pro-Pro in the C-terminal region. Modified protein was expressed in Escherichia coli Origami (DE3) and was purified. The culture conditions, including the culture media, temperature, agitation speed and air flow were tested in order to obtain an increased expression levels of the modified protein. A 2(3) factorial design was used for evaluate the effect of environmental conditions on modified protein production. The results indicated that the yield of modified protein could be increased by up 3-fold in bioreactor as compared with flask. In addition, the temperature, the agitation speed and the oxygen were significant factors on the expression of the antihypertensive protein. The maximum production was 99 mg protein-L(-1). The hydrolyzed protein showed a high inhibitory activity of the angiotensin converting enzyme (IC50=0.047 mg mL(-1)). ► We inserted 4 VY and 1 IPP antihypertensive peptides in the amarantin acidic subunit. ► Modified protein was overexpressed in Escherichia coli in a fermentor finding the best factors. ► The temperature, agitation speed and oxygen had effect on the yield of the protein. ► Modified protein is ten times more active than the non-modified sample. Amaranth seeds are considered as an excellent complementary source of food protein due to their balanced amino acid composition. Amarantin acidic subunit has the potential as a functional and nutraceutical protein, and it is structurally a good candidate for modification. The aim of this work was to improve its functionality, then the primary structure was modified into the third variable region of 11S globulins, by inserting antihypertensive peptides: four Val-Tyr in tandem and Arg-Ile-Pro-Pro in the C-terminal region. Modified protein was expressed in Escherichia coli Origami (DE3) and was purified. The culture conditions, including the culture media, temperature, agitation speed and air flow were tested in order to obtain an increased expression levels of the modified protein. A 23 factorial design was used for evaluate the effect of environmental conditions on modified protein production. The results indicated that the yield of modified protein could be increased by up 3-fold in bioreactor as compared with flask. In addition, the temperature, the agitation speed and the oxygen were significant factors on the expression of the antihypertensive protein. The maximum production was 99mg protein-L−1. The hydrolyzed protein showed a high inhibitory activity of the angiotensin converting enzyme (IC50=0.047mgmL−1). Amaranth seeds are considered as an excellent complementary source of food protein due to their balanced amino acid composition. Amarantin acidic subunit has the potential as a functional and nutraceutical protein, and it is structurally a good candidate for modification. The aim of this work was to improve its functionality, then the primary structure was modified into the third variable region of 11S globulins, by inserting antihypertensive peptides: four Val-Tyr in tandem and Arg-Ile-Pro-Pro in the C-terminal region. Modified protein was expressed in Escherichia coli Origami (DE3) and was purified. The culture conditions, including the culture media, temperature, agitation speed and air flow were tested in order to obtain an increased expression levels of the modified protein. A 2(3) factorial design was used for evaluate the effect of environmental conditions on modified protein production. The results indicated that the yield of modified protein could be increased by up 3-fold in bioreactor as compared with flask. In addition, the temperature, the agitation speed and the oxygen were significant factors on the expression of the antihypertensive protein. The maximum production was 99 mg protein-L(-1). The hydrolyzed protein showed a high inhibitory activity of the angiotensin converting enzyme (IC50=0.047 mg mL(-1)).Amaranth seeds are considered as an excellent complementary source of food protein due to their balanced amino acid composition. Amarantin acidic subunit has the potential as a functional and nutraceutical protein, and it is structurally a good candidate for modification. The aim of this work was to improve its functionality, then the primary structure was modified into the third variable region of 11S globulins, by inserting antihypertensive peptides: four Val-Tyr in tandem and Arg-Ile-Pro-Pro in the C-terminal region. Modified protein was expressed in Escherichia coli Origami (DE3) and was purified. The culture conditions, including the culture media, temperature, agitation speed and air flow were tested in order to obtain an increased expression levels of the modified protein. A 2(3) factorial design was used for evaluate the effect of environmental conditions on modified protein production. The results indicated that the yield of modified protein could be increased by up 3-fold in bioreactor as compared with flask. In addition, the temperature, the agitation speed and the oxygen were significant factors on the expression of the antihypertensive protein. The maximum production was 99 mg protein-L(-1). The hydrolyzed protein showed a high inhibitory activity of the angiotensin converting enzyme (IC50=0.047 mg mL(-1)). Amaranth seeds are considered as an excellent complementary source of food protein due to their balanced amino acid composition. Amarantin acidic subunit has the potential as a functional and nutraceutical protein, and it is structurally a good candidate for modification. The aim of this work was to improve its functionality, then the primary structure was modified into the third variable region of 11S globulins, by inserting antihypertensive peptides: four Val-Tyr in tandem and Arg-Ile-Pro-Pro in the C-terminal region. Modified protein was expressed in Escherichia coli Origami (DE3) and was purified. The culture conditions, including the culture media, temperature, agitation speed and air flow were tested in order to obtain an increased expression levels of the modified protein. A 2³ factorial design was used for evaluate the effect of environmental conditions on modified protein production. The results indicated that the yield of modified protein could be increased by up 3-fold in bioreactor as compared with flask. In addition, the temperature, the agitation speed and the oxygen were significant factors on the expression of the antihypertensive protein. The maximum production was 99mg protein-L¹. The hydrolyzed protein showed a high inhibitory activity of the angiotensin converting enzyme (IC₅†=0.047mgmL¹). Amaranth seeds are considered as an excellent complementary source of food protein due to their balanced amino acid composition. Amarantin acidic subunit has the potential as a functional and nutraceutical protein, and it is structurally a good candidate for modification. The aim of this work was to improve its functionality, then the primary structure was modified into the third variable region of 11S globulins, by inserting antihypertensive peptides: four Val-Tyr in tandem and Arg-Ile-Pro-Pro in the C-terminal region. Modified protein was expressed in Escherichia coli Origami (DE3) and was purified. The culture conditions, including the culture media, temperature, agitation speed and air flow were tested in order to obtain an increased expression levels of the modified protein. A 2³ factorial design was used for evaluate the effect of environmental conditions on modified protein production. The results indicated that the yield of modified protein could be increased by up 3-fold in bioreactor as compared with flask. In addition, the temperature, the agitation speed and the oxygen were significant factors on the expression of the antihypertensive protein. The maximum production was 99mg protein-L⁻¹. The hydrolyzed protein showed a high inhibitory activity of the angiotensin converting enzyme (IC₅₀=0.047mgmL⁻¹). |
Author | Paredes-López, Octavio Luna-Suárez, Silvia Castro-Martínez, Claudia |
Author_xml | – sequence: 1 givenname: Claudia surname: Castro-Martínez fullname: Castro-Martínez, Claudia organization: Centro de Investigación para el Desarrollo Integral Regional, CIDIIR-IPN, Sinaloa, Mexico – sequence: 2 givenname: Silvia surname: Luna-Suárez fullname: Luna-Suárez, Silvia organization: Centro de Investigación en Biotecnología Aplicada, CIBA - IPN, Mexico – sequence: 3 givenname: Octavio surname: Paredes-López fullname: Paredes-López, Octavio email: oparedes@ira.cinvestav.mx organization: Departamento de Biotecnología y Bioquímica, Centro de Investigación y de Estudios Avanzados del IPN, Apdo. Postal 629, 36821 Irapuato, Gto., Mexico |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22248593$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc2OFCEUhYkZ4_SMPoLKTjdVAkVVUXFhzGT8SSaZhc6aUHDLplMFLdAdfQcf2tvpdkxcOCsIfOceOOeCnIUYgJDnnNWc8e7Npt6MPhawtWCc11zUjItHZMVV31RSdc0ZWSGnKt613Tm5yHnDGJNDy5-QcyGEVO3QrMiv2z0k-LFNkLOPgcaJGrpE5ycPjm4TOvhApxQXahaTTChrmgGv8PQ62zUkb9feUBtnT01wFKYJbDnMgbD3KYYFQjEzAsH5ghaZok1Zw_3wv-5PyePJzBmendZLcvfh-uvVp-rm9uPnq_c3lZWCl8o0XCkJ-JtW4aYXQ8uYUFxyAS1rZe_MqIbR9IMbDRsbMQI30rZusH0nx6a5JK-Oc_EJ33eQi158tjDPJkDcZT1gPEOvGonk6_-SGHDXC6U6geiLE7obF3B6mzwG9lP_yRqB9gjYFHNOMN0jnOlDp3qjT53qQ6eaC42dou7tPzrrizlEWZLx84Pql0f1ZKI235LP-u4LAhgZ7zDOAYl3RwIw8r2HpLP1ECw4n7BK7aJ_wOM3ZGnK2A |
CitedBy_id | crossref_primary_10_1080_08905436_2019_1571420 crossref_primary_10_1080_19476337_2024_2375253 crossref_primary_10_3389_fpls_2020_578631 crossref_primary_10_1002_bit_27373 crossref_primary_10_48077_scihor_25_11__2022_63_73 crossref_primary_10_1016_j_jbiotec_2016_07_007 crossref_primary_10_1007_s00253_019_09633_1 crossref_primary_10_1007_s11240_012_0271_1 crossref_primary_10_1002_cben_201600002 crossref_primary_10_1007_s11274_023_03553_z crossref_primary_10_1016_j_jff_2013_06_001 crossref_primary_10_1080_10408398_2023_2294164 crossref_primary_10_1007_s11033_019_04604_1 crossref_primary_10_1016_j_ejbt_2016_04_001 crossref_primary_10_1016_j_ejbt_2018_11_001 crossref_primary_10_1016_j_procbio_2015_01_017 crossref_primary_10_1007_s00253_018_9300_2 crossref_primary_10_1080_10408398_2018_1434480 crossref_primary_10_1007_s00253_020_10454_w |
Cites_doi | 10.1093/ajcn.70.2.221 10.1007/s00253-010-2488-4 10.1073/pnas.0832158100 10.1017/S0007114500002221 10.1021/jf990366z 10.1016/j.jbiotec.2008.03.003 10.1046/j.1440-1681.2002.03628.x 10.1093/ajcn/77.2.326 10.1093/ajcn/64.5.767 10.1038/sj.jhh.1001065 10.1080/07315724.2005.10719473 10.1016/j.phytochem.2009.04.006 10.1016/j.jnutbio.2007.11.010 10.1111/j.1745-4514.1995.tb00538.x 10.1161/01.HYP.15.3.327 10.1021/jf063427j 10.1002/biot.200700146 10.1016/j.tibtech.2009.04.002 10.1038/sj.jhh.1001745 10.1007/s10529-004-6040-4 10.1021/jf903261h 10.1016/j.jbiotec.2004.09.013 10.4014/jmb.0905.05055 10.1007/s11248-009-9272-1 10.3168/jds.2007-0413 10.1089/jmf.2009.0159 10.1021/bp049923e 10.1016/S1367-5931(02)00019-4 10.1038/227680a0 10.1016/j.jbiotec.2010.01.010 10.1007/b93995 10.1080/00325481.2001.11445493 10.1021/jf0508908 10.1016/j.peptides.2005.11.007 10.1016/j.peptides.2008.02.005 10.3168/jds.2009-2566 10.1021/jf0713354 10.1016/j.idairyj.2005.12.011 10.1038/nbt1029 10.1291/hypres.28.545 10.1021/jf060264q 10.1002/bit.22274 10.1007/s00122-003-1430-x 10.1079/BJN20051422 10.2174/138161207780363068 10.1016/j.idairyj.2005.01.001 10.3168/jds.S0022-0302(95)76689-9 10.1016/0958-1669(95)80087-5 10.1105/tpc.2.5.403 10.1002/jsfa.1120 10.1016/j.jbiotec.2010.06.009 |
ContentType | Journal Article |
Copyright | 2012 Elsevier B.V. Copyright © 2012 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2012 Elsevier B.V. – notice: Copyright © 2012 Elsevier B.V. All rights reserved. |
DBID | FBQ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8 |
DOI | 10.1016/j.jbiotec.2011.12.012 |
DatabaseName | AGRIS CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1873-4863 |
EndPage | 67 |
ExternalDocumentID | 22248593 10_1016_j_jbiotec_2011_12_012 US201500164219 S0168165611006687 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AAAJQ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABNUV ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEWK ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AHHHB AHPOS AIEXJ AIKHN AITUG AJBFU AJOXV AKURH ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CJTIS CNWQP CS3 DOVZS DU5 EBS EFJIC EFLBG EJD ENUVR EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA HZ~ IHE J1W KOM LUGTX LX3 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SDF SDG SDP SES SPC SPCBC SSG SSI SSU SSZ T5K ZMT ~02 ~G- ~KM .GJ 29K 53G AAHBH AAQXK AATTM AAXKI ABDPE ABWVN ACRPL ADNMO ADVLN AEIPS AFJKZ AGRDE AKRWK ANKPU ASPBG AVWKF AZFZN BNPGV D-I FBQ FEDTE FGOYB G-2 HLW HMG HVGLF R2- SBG SEW SIN SSH WUQ XPP Y6R AAYWO AAYXX ACVFH ADCNI AEUPX AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKYEP APXCP CITATION CGR CUY CVF ECM EFKBS EIF NPM 7S9 L.6 7X8 |
ID | FETCH-LOGICAL-c421t-a31884e00458884729500281412e50547dab89ba79dba0b32be1a4c5d9c764b33 |
IEDL.DBID | .~1 |
ISSN | 0168-1656 1873-4863 |
IngestDate | Mon Jul 21 11:24:49 EDT 2025 Fri Jul 11 03:02:00 EDT 2025 Mon Jul 21 06:03:33 EDT 2025 Thu Apr 24 23:05:01 EDT 2025 Tue Jul 01 02:08:08 EDT 2025 Thu Apr 03 09:44:43 EDT 2025 Fri Feb 23 02:23:54 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1-2 |
Keywords | 11S acidic subunit ACE inhibitory activity Amaranth seed Antihypertensive peptides |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2012 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c421t-a31884e00458884729500281412e50547dab89ba79dba0b32be1a4c5d9c764b33 |
Notes | http://dx.doi.org/10.1016/j.jbiotec.2011.12.012 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 22248593 |
PQID | 1686728862 |
PQPubID | 24069 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_922497834 proquest_miscellaneous_1686728862 pubmed_primary_22248593 crossref_primary_10_1016_j_jbiotec_2011_12_012 crossref_citationtrail_10_1016_j_jbiotec_2011_12_012 fao_agris_US201500164219 elsevier_sciencedirect_doi_10_1016_j_jbiotec_2011_12_012 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-03-31 |
PublicationDateYYYYMMDD | 2012-03-31 |
PublicationDate_xml | – month: 03 year: 2012 text: 2012-03-31 day: 31 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of biotechnology |
PublicationTitleAlternate | J Biotechnol |
PublicationYear | 2012 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Hartmann, Kaar, Falconer, Zeng, Middelberg (bib0080) 2008; 135 Laemmli (bib0120) 1970; 227 Rao, Yujie, Junhua, Zhenzhen, Yanjun (bib0210) 2009; 19 Prak, Maruyama, Maruyama, Utsumi (bib0200) 2006; 27 Romero-Zepeda, Paredes-López (bib0230) 1996; 19 Adachi, Kanamori, Masuda, Yagasaki, Nikamura, Mikami, Utsumi (bib0005) 2003; 100 Kawasaki, Seki, Osajima, Yoshida, Asada, Matsui, Osajima (bib0105) 2000; 14 Sambrook, Fritsch, Maniatis (bib0235) 1989 Yokoyama (bib0295) 2003; 7 Nakamura, Yamamoto, Sakai, Okubo, Yamazaki, Takano (bib0190) 1995; 78 Fahnert, Lile, Neubauer (bib0060) 2004; 89 Hata, Yamamoto Ohni, Nakajima, Nakamura, Takano (bib0085) 1996; 64 Wright (bib0285) 1988 Hernández-Ledesma, Amigo, Recio, Bartolomé (bib0090) 2007; 55 Matsui, Ueno, Tanaka, Oka, Miyamoto, Osajima, Matsumoto (bib0150) 2005; 28 Vecchi, Añón (bib0275) 2009; 70 Keil (bib0110) 1992; vol. 335 Fitzgerald, Meisel (bib0065) 2000; 84 Hong, Ming, Yi, Zhanxia, Yongquan, Chi (bib0095) 2008; 29 Madureira, Tavares, Gomes, Pintado, Malcata (bib0135) 2010; 93 Seppo, Jauhiainen, Poussa, Korpela (bib0240) 2003; 77 Matsui, Tamaya, Sekji, Osajima, Matsumoto, Kawasaki (bib0145) 2002; 29 Luna-Suárez, Medina-Godoy, Cruz-Hernández, Paredes-López (bib0130) 2010; 148 Chobanian, Haudenschild, Nickerson, Drago (bib0040) 1990; 15 Nakahara, Sano, Yamaguchi, Sugimoto, Chikata, Kinoshita, Uchida (bib0180) 2010; 58 Quirós, Ramos, Muguerza, Delgado, Miguel, Aleixandre, Recio (bib0205) 2007; 17 Vercruysse, Van Camp, Smagghe (bib0280) 2005; 53 Luna-Suárez, Medina-Godoy, Cruz-Hernández, Paredes-López (bib0125) 2008; 3 Berrow, Büssow, Coutard, Diprose, Ekberg, Folkers, Levy, Lieu, Owens, Peleg, Pinaglia, Quevillon-Cheruel, Salim, Scheich, Vincentelli, Busso (bib0025) 2006; 62 Erdmann, Wheung, Schröder (bib0055) 2008; 19 Rascón-Cruz, Sinagawa-García, Osuna-Castro, Bohorova, Paredes-López (bib0215) 2004; 108 Baneyx, Mujacic (bib0020) 2004; 22 Valdez-Ortiz, Rascón-Cruz, Medina-Godoy, Sinagawa-García, Valverde-González, Paredes-López (bib0270) 2005; 115 Tai, Wu, Chen, Tzen (bib0250) 1999; 47 Moers, Wolbert, de Wolf, Werten (bib0165) 2010; 146 Kyle, Aggeli, Ingham, McPherson (bib0115) 2009; 27 Tsai, Mann, Morris, Rotgers, Fenton (bib0260) 1987; 2 Glasser (bib0070) 2001; 110 Akama, Kanetou, Shimosaki, Kawakami, Tsuchikura, Takaiwa (bib0015) 2009; 18 Yazdani, Shakri, Chitnis (bib0290) 2004; 26 Aihara, Kajimoto, Hirata, Takahashi, Nakamura (bib0010) 2005; 24 Murray, FitzGerald (bib0175) 2007; 13 Seppo, Kerojoki, Suomalainen, Korpela (bib0245) 2002; 57 Nakamura, Mizutani, Sasaki, Yamamoto, Takazawa (bib0185) 2009; 12 Medina-Godoy, Nielsen, Paredes-López (bib0155) 2004; 20 Romanos (bib0225) 1995; 6 Cao, Zhang, Ji, Hao (bib0035) 2011; 6 Cinq-Mars, Li-Chan (bib0045) 2007; 55 Tuomilehto, Lindström, Hyreynen, Korpela, Karhunen, Mikkola, Jauhiainen, Seppo, Nissinen (bib0265) 2004; 18 Hu, Stampfer, Manson, Rimm, Colditz, Speizer, Hennekens (bib0100) 1999; 70 Mizuno, Matsuura, Gotou, Nishimura, Kajimoto, Yabune, Kajimoto, Yamamoto (bib0160) 2005; 94 Riley, Aggeli, Koopmans, McPherson (bib0220) 2009; 103 Tripathi, Shukla, Biswal, Rao (bib0255) 2010; 86 Gorinstein, Pawelzik, Delgado-Licon, Haruenkint, Weisz, Trakhtenberg (bib0075) 2002; 82 Dickinson, Scott, Hussein, Argos, Nielsen (bib0050) 1990; 2 Mallikarjun, Gowda, Rao, Prakash (bib0140) 2006; 54 Bütikofer, Meyer, Walther, Wechsler (bib0030) 2008; 91 Muguerza, Ramos, Sánchez, Manso, Miguel, Aleixandre, Delgado, Recio (bib0170) 2006; 16 Rascón-Cruz (10.1016/j.jbiotec.2011.12.012_bib0215) 2004; 108 Aihara (10.1016/j.jbiotec.2011.12.012_bib0010) 2005; 24 Mallikarjun (10.1016/j.jbiotec.2011.12.012_bib0140) 2006; 54 Medina-Godoy (10.1016/j.jbiotec.2011.12.012_bib0155) 2004; 20 Madureira (10.1016/j.jbiotec.2011.12.012_bib0135) 2010; 93 Luna-Suárez (10.1016/j.jbiotec.2011.12.012_bib0125) 2008; 3 Gorinstein (10.1016/j.jbiotec.2011.12.012_bib0075) 2002; 82 Berrow (10.1016/j.jbiotec.2011.12.012_bib0025) 2006; 62 Hong (10.1016/j.jbiotec.2011.12.012_bib0095) 2008; 29 Seppo (10.1016/j.jbiotec.2011.12.012_bib0245) 2002; 57 Erdmann (10.1016/j.jbiotec.2011.12.012_bib0055) 2008; 19 Moers (10.1016/j.jbiotec.2011.12.012_bib0165) 2010; 146 Murray (10.1016/j.jbiotec.2011.12.012_bib0175) 2007; 13 Quirós (10.1016/j.jbiotec.2011.12.012_bib0205) 2007; 17 Rao (10.1016/j.jbiotec.2011.12.012_bib0210) 2009; 19 Tripathi (10.1016/j.jbiotec.2011.12.012_bib0255) 2010; 86 Cao (10.1016/j.jbiotec.2011.12.012_bib0035) 2011; 6 Valdez-Ortiz (10.1016/j.jbiotec.2011.12.012_bib0270) 2005; 115 Muguerza (10.1016/j.jbiotec.2011.12.012_bib0170) 2006; 16 Vecchi (10.1016/j.jbiotec.2011.12.012_bib0275) 2009; 70 Seppo (10.1016/j.jbiotec.2011.12.012_bib0240) 2003; 77 Romanos (10.1016/j.jbiotec.2011.12.012_bib0225) 1995; 6 Matsui (10.1016/j.jbiotec.2011.12.012_bib0145) 2002; 29 Fitzgerald (10.1016/j.jbiotec.2011.12.012_bib0065) 2000; 84 Vercruysse (10.1016/j.jbiotec.2011.12.012_bib0280) 2005; 53 Sambrook (10.1016/j.jbiotec.2011.12.012_bib0235) 1989 Hu (10.1016/j.jbiotec.2011.12.012_bib0100) 1999; 70 Cinq-Mars (10.1016/j.jbiotec.2011.12.012_bib0045) 2007; 55 Chobanian (10.1016/j.jbiotec.2011.12.012_bib0040) 1990; 15 Glasser (10.1016/j.jbiotec.2011.12.012_bib0070) 2001; 110 Dickinson (10.1016/j.jbiotec.2011.12.012_bib0050) 1990; 2 Tsai (10.1016/j.jbiotec.2011.12.012_bib0260) 1987; 2 Matsui (10.1016/j.jbiotec.2011.12.012_bib0150) 2005; 28 Bütikofer (10.1016/j.jbiotec.2011.12.012_bib0030) 2008; 91 Romero-Zepeda (10.1016/j.jbiotec.2011.12.012_bib0230) 1996; 19 Yokoyama (10.1016/j.jbiotec.2011.12.012_bib0295) 2003; 7 Kyle (10.1016/j.jbiotec.2011.12.012_bib0115) 2009; 27 Nakamura (10.1016/j.jbiotec.2011.12.012_bib0190) 1995; 78 Baneyx (10.1016/j.jbiotec.2011.12.012_bib0020) 2004; 22 Riley (10.1016/j.jbiotec.2011.12.012_bib0220) 2009; 103 Wright (10.1016/j.jbiotec.2011.12.012_bib0285) 1988 Adachi (10.1016/j.jbiotec.2011.12.012_bib0005) 2003; 100 Hernández-Ledesma (10.1016/j.jbiotec.2011.12.012_bib0090) 2007; 55 Tai (10.1016/j.jbiotec.2011.12.012_bib0250) 1999; 47 Prak (10.1016/j.jbiotec.2011.12.012_bib0200) 2006; 27 Fahnert (10.1016/j.jbiotec.2011.12.012_bib0060) 2004; 89 Kawasaki (10.1016/j.jbiotec.2011.12.012_bib0105) 2000; 14 Laemmli (10.1016/j.jbiotec.2011.12.012_bib0120) 1970; 227 Mizuno (10.1016/j.jbiotec.2011.12.012_bib0160) 2005; 94 Hartmann (10.1016/j.jbiotec.2011.12.012_bib0080) 2008; 135 Yazdani (10.1016/j.jbiotec.2011.12.012_bib0290) 2004; 26 Nakamura (10.1016/j.jbiotec.2011.12.012_bib0185) 2009; 12 Luna-Suárez (10.1016/j.jbiotec.2011.12.012_bib0130) 2010; 148 Akama (10.1016/j.jbiotec.2011.12.012_bib0015) 2009; 18 Keil (10.1016/j.jbiotec.2011.12.012_bib0110) 1992; vol. 335 Hata (10.1016/j.jbiotec.2011.12.012_bib0085) 1996; 64 Nakahara (10.1016/j.jbiotec.2011.12.012_bib0180) 2010; 58 Tuomilehto (10.1016/j.jbiotec.2011.12.012_bib0265) 2004; 18 |
References_xml | – volume: 3 start-page: 209 year: 2008 end-page: 219 ident: bib0125 article-title: Expression and characterization of the acidic subunit from 11S amaranth seed protein publication-title: Biotech. J. – volume: 100 start-page: 7395 year: 2003 end-page: 7400 ident: bib0005 article-title: Crystal structure of soybean 11S globulin: glycinin A3B4 homohexamer publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 89 start-page: 93 year: 2004 end-page: 142 ident: bib0060 article-title: Inclusion bodies: formation and utilization publication-title: Adv. Biochem. Eng./Biotechnol. – volume: 82 start-page: 886 year: 2002 end-page: 891 ident: bib0075 article-title: Characterisation of pseudocereal and cereal proteins by protein and amino acid analyses publication-title: J. Sci. Food Agric. – volume: 19 start-page: 1620 year: 2009 end-page: 1627 ident: bib0210 article-title: Design and expression of recombinant antihypertensive peptide multimer gene in publication-title: J. Microbiol. Biotechnol. – volume: 135 start-page: 85 year: 2008 end-page: 91 ident: bib0080 article-title: Expression and purification of a nanostructure-forming peptide publication-title: J. Biotechnol. – volume: 84 start-page: S33 year: 2000 end-page: S37 ident: bib0065 article-title: Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme publication-title: Br. J. Nutr. – volume: 115 start-page: 413 year: 2005 end-page: 423 ident: bib0270 article-title: One-step purification and structural characterization of a recombinant His-tag 11S globulin expressed in transgenic tobacco publication-title: J. Biotechnol. – volume: 27 start-page: 423 year: 2009 end-page: 433 ident: bib0115 article-title: Production of self-assembling biomaterials for tissue engineering publication-title: Trends Biotechnol. – volume: 22 start-page: 1399 year: 2004 end-page: 1408 ident: bib0020 article-title: Recombinant protein folding and misfolding in publication-title: Nat. Biotechnol. – volume: 17 start-page: 33 year: 2007 end-page: 41 ident: bib0205 article-title: Identification of novel antihypertensive peptides in milk fermented with publication-title: Int. Dairy J. – volume: 15 start-page: 327 year: 1990 end-page: 331 ident: bib0040 article-title: Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit publication-title: Hypertension – volume: 12 start-page: 1221 year: 2009 end-page: 1226 ident: bib0185 article-title: Benefical potential of casein hydrolisate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study publication-title: J. Med. Food – volume: 94 start-page: 84 year: 2005 end-page: 91 ident: bib0160 article-title: Antihypertensive effect of casein hydrolisate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension publication-title: Br. J. Nutr. – volume: 78 start-page: 777 year: 1995 end-page: 783 ident: bib0190 article-title: Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk publication-title: J. Dairy Sci. – volume: 28 start-page: 545 year: 2005 end-page: 552 ident: bib0150 article-title: Antiproliferative action of an angiotensin I-converting enzyme inhibitory peptide, Val-Tyr, via an L-type Ca publication-title: Hypertens. Res. – volume: 70 start-page: 864 year: 2009 end-page: 870 ident: bib0275 article-title: ACE inhibitory tetrapeptides from publication-title: Phytochemistry – volume: 26 start-page: 1891 year: 2004 end-page: 1895 ident: bib0290 article-title: A high cell density cultivation strategy to produce recombinant malarial antigen in publication-title: Biotechnol. Lett. – volume: vol. 335 year: 1992 ident: bib0110 publication-title: Specificity of Proteolysis – volume: 55 start-page: 3392 year: 2007 end-page: 3397 ident: bib0090 article-title: ACE-inhibitory and radical-scavenging activity of peptides derived from β-lactoglobulin f(19-25). Interactions with ascorbic acid publication-title: J. Agric. Food Chem. – volume: 110 start-page: 29 year: 2001 end-page: 36 ident: bib0070 article-title: Hypertension syndrome and cardiovascular events publication-title: Postgrad. Med. – volume: 29 start-page: 1062 year: 2008 end-page: 1071 ident: bib0095 article-title: The antihypertensive effect of peptides: a novel alternative to drugs? publication-title: Peptides – volume: 55 start-page: 9380 year: 2007 end-page: 9388 ident: bib0045 article-title: Optimizing angiotensin I-converting enzyme inhibitory activity of pacific hake ( publication-title: J. Agric. Food Chem. – volume: 64 start-page: 767 year: 1996 end-page: 771 ident: bib0085 article-title: A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects publication-title: Am. J. Clin. Nutr. – volume: 14 start-page: 519 year: 2000 end-page: 523 ident: bib0105 article-title: Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects publication-title: J. Hum. Hypertens. – volume: 6 start-page: 527 year: 1995 end-page: 533 ident: bib0225 article-title: Advances in the use of publication-title: Curr. Opin. Biotechnol. – volume: 70 start-page: 221 year: 1999 end-page: 227 ident: bib0100 article-title: Dietary protein and risk of ischemic heart disease in women publication-title: Am. J. Clin. Nutr. – volume: 77 start-page: 326 year: 2003 end-page: 330 ident: bib0240 article-title: A fermented milk high in bioactive peptides has a blood pressure lowering effect in hypertensive subjects publication-title: Am. J. Clin. Nutr. – volume: 20 start-page: 1749 year: 2004 end-page: 1756 ident: bib0155 article-title: Expression and characterization of a His-tagged 11S seed globulin from publication-title: Biotechnol. Prog. – start-page: 119 year: 1988 end-page: 177 ident: bib0285 article-title: The seed globulins-Part II publication-title: Developments in Food Proteins – volume: 19 start-page: 643 year: 2008 end-page: 654 ident: bib0055 article-title: The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease publication-title: J. Nutr. Biochem. – volume: 16 start-page: 61 year: 2006 end-page: 69 ident: bib0170 article-title: Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk publication-title: Int. Dairy J. – volume: 53 start-page: 8106 year: 2005 end-page: 8115 ident: bib0280 article-title: ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: a review publication-title: J. Agric. Food Chem. – volume: 19 start-page: 329 year: 1996 end-page: 339 ident: bib0230 article-title: Isolation and characterization of amarantin, the 11S amaranth seed globulin publication-title: J. Food Biochem. – volume: 86 start-page: 1795 year: 2010 end-page: 1803 ident: bib0255 article-title: Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein publication-title: Appl. Microbiol. Biotechnol. – volume: 24 start-page: 257 year: 2005 end-page: 265 ident: bib0010 article-title: Effect of powdered fermented milk with publication-title: J. Am. Coll. Nutr. – volume: 13 start-page: 773 year: 2007 end-page: 791 ident: bib0175 article-title: Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production publication-title: Curr. Pharm. Des. – volume: 47 start-page: 4932 year: 1999 end-page: 4938 ident: bib0250 article-title: Molecular cloning of 11S globulin and 2S albumin, the two major seed storage proteins in sesame publication-title: J. Agric. Food Chem. – volume: 2 start-page: 403 year: 1990 end-page: 413 ident: bib0050 article-title: Effect of structural modifications on the assembly of a glycinin subunit publication-title: Plant Cell – volume: 146 start-page: 66 year: 2010 end-page: 73 ident: bib0165 article-title: Secreted production of self-assembling peptides in publication-title: J. Biotechol. – year: 1989 ident: bib0235 article-title: Molecular Cloning: A Laboratory Manual – volume: 29 start-page: 204 year: 2002 end-page: 208 ident: bib0145 article-title: Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system publication-title: Clin. Exp. Pharmacol. Physiol. – volume: 27 start-page: 1179 year: 2006 end-page: 1186 ident: bib0200 article-title: Design of genetically modified soybean proglycinin A1aB1b with multiple copies of bioactive peptide sequences publication-title: Peptides – volume: 7 start-page: 39 year: 2003 end-page: 43 ident: bib0295 article-title: Protein expression systems for structural genomics and proteomics publication-title: Curr. Opin. Chem. Biol. – volume: 18 start-page: 865 year: 2009 end-page: 876 ident: bib0015 article-title: Seed-specific expression of truncated publication-title: Transgenic Res. – volume: 54 start-page: 4568 year: 2006 end-page: 4573 ident: bib0140 article-title: Angiotensin I-cornverting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean ( publication-title: J. Agric. Food Chem. – volume: 103 start-page: 241 year: 2009 end-page: 251 ident: bib0220 article-title: Bioproduction and characterization of a pH responsive self-assembling peptide publication-title: Biotechnol. Bioeng. – volume: 227 start-page: 680 year: 1970 end-page: 685 ident: bib0120 article-title: Cleavage of structural proteins during the assembly of the head of bacteriophage T4 publication-title: Nature – volume: 148 start-page: 240 year: 2010 end-page: 247 ident: bib0130 article-title: Modification of the amaranth 11S globulin storage protein to produce an inhibitory peptide of the angiotensin I converting enzyme, and its expression in publication-title: J. Biotechnol. – volume: 91 start-page: 29 year: 2008 end-page: 38 ident: bib0030 article-title: Ocurrence of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in different cheese varieties of Swiss origin publication-title: J. Dairy Sci. – volume: 18 start-page: 795 year: 2004 end-page: 802 ident: bib0265 article-title: Effect of ingesting sour milk fermented using publication-title: J. Hum. Hypertens. – volume: 93 start-page: 437 year: 2010 end-page: 455 ident: bib0135 article-title: Physiological properties of bioactive peptides obtained from whey proteins publication-title: J. Dairy Sci. – volume: 57 start-page: 124 year: 2002 end-page: 127 ident: bib0245 article-title: The effect of a publication-title: Milchwissenschaft – volume: 108 start-page: 335 year: 2004 end-page: 342 ident: bib0215 article-title: Accumulation, assemb1y, and digestibility of amarantin expressed in transgenic tropical maize publication-title: Theor. Appl. Genet. – volume: 62 start-page: 1218 year: 2006 end-page: 1226 ident: bib0025 article-title: Recombinant protein expression and solubility screening in publication-title: Acta Cryst. – volume: 6 year: 2011 ident: bib0035 article-title: Optimization of peptic hydrolysis parameters for the production of angiotensin I-converting enzyme inhibitory hydrolysate from publication-title: J. Sci. Food Agric. – volume: 58 start-page: 821 year: 2010 end-page: 827 ident: bib0180 article-title: Antihipertensive effect of peptide-enriched soy sauce-like seasoning and identification of its angiotensin I-converting enzyme inhibitory substances publication-title: J. Agric. Food Chem. – volume: 2 start-page: 181 year: 1987 end-page: 186 ident: bib0260 article-title: The effect of organic nitrogen and glucose on the production of recombinant human insulin-like growth factor in high cell density publication-title: J. Ind. Microbiol. Biotechnol. – volume: 70 start-page: 221 year: 1999 ident: 10.1016/j.jbiotec.2011.12.012_bib0100 article-title: Dietary protein and risk of ischemic heart disease in women publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn.70.2.221 – volume: 86 start-page: 1795 year: 2010 ident: 10.1016/j.jbiotec.2011.12.012_bib0255 article-title: Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein publication-title: Appl. Microbiol. Biotechnol. doi: 10.1007/s00253-010-2488-4 – volume: 100 start-page: 7395 year: 2003 ident: 10.1016/j.jbiotec.2011.12.012_bib0005 article-title: Crystal structure of soybean 11S globulin: glycinin A3B4 homohexamer publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0832158100 – volume: 84 start-page: S33 year: 2000 ident: 10.1016/j.jbiotec.2011.12.012_bib0065 article-title: Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme publication-title: Br. J. Nutr. doi: 10.1017/S0007114500002221 – start-page: 119 year: 1988 ident: 10.1016/j.jbiotec.2011.12.012_bib0285 article-title: The seed globulins-Part II – volume: 47 start-page: 4932 year: 1999 ident: 10.1016/j.jbiotec.2011.12.012_bib0250 article-title: Molecular cloning of 11S globulin and 2S albumin, the two major seed storage proteins in sesame publication-title: J. Agric. Food Chem. doi: 10.1021/jf990366z – volume: 135 start-page: 85 year: 2008 ident: 10.1016/j.jbiotec.2011.12.012_bib0080 article-title: Expression and purification of a nanostructure-forming peptide publication-title: J. Biotechnol. doi: 10.1016/j.jbiotec.2008.03.003 – volume: 29 start-page: 204 year: 2002 ident: 10.1016/j.jbiotec.2011.12.012_bib0145 article-title: Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system publication-title: Clin. Exp. Pharmacol. Physiol. doi: 10.1046/j.1440-1681.2002.03628.x – volume: 77 start-page: 326 year: 2003 ident: 10.1016/j.jbiotec.2011.12.012_bib0240 article-title: A fermented milk high in bioactive peptides has a blood pressure lowering effect in hypertensive subjects publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/77.2.326 – volume: vol. 335 year: 1992 ident: 10.1016/j.jbiotec.2011.12.012_bib0110 – volume: 64 start-page: 767 year: 1996 ident: 10.1016/j.jbiotec.2011.12.012_bib0085 article-title: A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/64.5.767 – volume: 14 start-page: 519 year: 2000 ident: 10.1016/j.jbiotec.2011.12.012_bib0105 article-title: Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects publication-title: J. Hum. Hypertens. doi: 10.1038/sj.jhh.1001065 – volume: 24 start-page: 257 year: 2005 ident: 10.1016/j.jbiotec.2011.12.012_bib0010 article-title: Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension publication-title: J. Am. Coll. Nutr. doi: 10.1080/07315724.2005.10719473 – volume: 70 start-page: 864 year: 2009 ident: 10.1016/j.jbiotec.2011.12.012_bib0275 article-title: ACE inhibitory tetrapeptides from Amaranthus hypochondriacus 11S globulin publication-title: Phytochemistry doi: 10.1016/j.phytochem.2009.04.006 – volume: 62 start-page: 1218 year: 2006 ident: 10.1016/j.jbiotec.2011.12.012_bib0025 article-title: Recombinant protein expression and solubility screening in Escherichia coli: a comparative study publication-title: Acta Cryst. – volume: 19 start-page: 643 year: 2008 ident: 10.1016/j.jbiotec.2011.12.012_bib0055 article-title: The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease publication-title: J. Nutr. Biochem. doi: 10.1016/j.jnutbio.2007.11.010 – volume: 19 start-page: 329 year: 1996 ident: 10.1016/j.jbiotec.2011.12.012_bib0230 article-title: Isolation and characterization of amarantin, the 11S amaranth seed globulin publication-title: J. Food Biochem. doi: 10.1111/j.1745-4514.1995.tb00538.x – volume: 57 start-page: 124 year: 2002 ident: 10.1016/j.jbiotec.2011.12.012_bib0245 article-title: The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension: a pilot study on humans publication-title: Milchwissenschaft – volume: 15 start-page: 327 year: 1990 ident: 10.1016/j.jbiotec.2011.12.012_bib0040 article-title: Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit publication-title: Hypertension doi: 10.1161/01.HYP.15.3.327 – volume: 6 year: 2011 ident: 10.1016/j.jbiotec.2011.12.012_bib0035 article-title: Optimization of peptic hydrolysis parameters for the production of angiotensin I-converting enzyme inhibitory hydrolysate from Acetes chinensis through Plackett–Burman and response surface methodological approaches publication-title: J. Sci. Food Agric. – volume: 55 start-page: 3392 year: 2007 ident: 10.1016/j.jbiotec.2011.12.012_bib0090 article-title: ACE-inhibitory and radical-scavenging activity of peptides derived from β-lactoglobulin f(19-25). Interactions with ascorbic acid publication-title: J. Agric. Food Chem. doi: 10.1021/jf063427j – volume: 3 start-page: 209 year: 2008 ident: 10.1016/j.jbiotec.2011.12.012_bib0125 article-title: Expression and characterization of the acidic subunit from 11S amaranth seed protein publication-title: Biotech. J. doi: 10.1002/biot.200700146 – volume: 27 start-page: 423 year: 2009 ident: 10.1016/j.jbiotec.2011.12.012_bib0115 article-title: Production of self-assembling biomaterials for tissue engineering publication-title: Trends Biotechnol. doi: 10.1016/j.tibtech.2009.04.002 – volume: 18 start-page: 795 year: 2004 ident: 10.1016/j.jbiotec.2011.12.012_bib0265 article-title: Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension publication-title: J. Hum. Hypertens. doi: 10.1038/sj.jhh.1001745 – volume: 26 start-page: 1891 year: 2004 ident: 10.1016/j.jbiotec.2011.12.012_bib0290 article-title: A high cell density cultivation strategy to produce recombinant malarial antigen in Escherichia coli publication-title: Biotechnol. Lett. doi: 10.1007/s10529-004-6040-4 – volume: 58 start-page: 821 year: 2010 ident: 10.1016/j.jbiotec.2011.12.012_bib0180 article-title: Antihipertensive effect of peptide-enriched soy sauce-like seasoning and identification of its angiotensin I-converting enzyme inhibitory substances publication-title: J. Agric. Food Chem. doi: 10.1021/jf903261h – volume: 115 start-page: 413 year: 2005 ident: 10.1016/j.jbiotec.2011.12.012_bib0270 article-title: One-step purification and structural characterization of a recombinant His-tag 11S globulin expressed in transgenic tobacco publication-title: J. Biotechnol. doi: 10.1016/j.jbiotec.2004.09.013 – volume: 19 start-page: 1620 year: 2009 ident: 10.1016/j.jbiotec.2011.12.012_bib0210 article-title: Design and expression of recombinant antihypertensive peptide multimer gene in Escherichia coli BL21 publication-title: J. Microbiol. Biotechnol. doi: 10.4014/jmb.0905.05055 – volume: 18 start-page: 865 year: 2009 ident: 10.1016/j.jbiotec.2011.12.012_bib0015 article-title: Seed-specific expression of truncated OsGAD2 produces GABA-enriched rice grains that influence a decrease in blood pressure in spontaneously hypertense rats publication-title: Transgenic Res. doi: 10.1007/s11248-009-9272-1 – volume: 91 start-page: 29 year: 2008 ident: 10.1016/j.jbiotec.2011.12.012_bib0030 article-title: Ocurrence of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in different cheese varieties of Swiss origin publication-title: J. Dairy Sci. doi: 10.3168/jds.2007-0413 – volume: 12 start-page: 1221 year: 2009 ident: 10.1016/j.jbiotec.2011.12.012_bib0185 article-title: Benefical potential of casein hydrolisate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study publication-title: J. Med. Food doi: 10.1089/jmf.2009.0159 – volume: 20 start-page: 1749 year: 2004 ident: 10.1016/j.jbiotec.2011.12.012_bib0155 article-title: Expression and characterization of a His-tagged 11S seed globulin from Amaranthus hypochondriacus in Escherichia coli publication-title: Biotechnol. Prog. doi: 10.1021/bp049923e – volume: 7 start-page: 39 year: 2003 ident: 10.1016/j.jbiotec.2011.12.012_bib0295 article-title: Protein expression systems for structural genomics and proteomics publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/S1367-5931(02)00019-4 – volume: 227 start-page: 680 year: 1970 ident: 10.1016/j.jbiotec.2011.12.012_bib0120 article-title: Cleavage of structural proteins during the assembly of the head of bacteriophage T4 publication-title: Nature doi: 10.1038/227680a0 – volume: 146 start-page: 66 year: 2010 ident: 10.1016/j.jbiotec.2011.12.012_bib0165 article-title: Secreted production of self-assembling peptides in Pichia pastoris by fusion to an artificial highly hydrophilic protein publication-title: J. Biotechol. doi: 10.1016/j.jbiotec.2010.01.010 – volume: 89 start-page: 93 year: 2004 ident: 10.1016/j.jbiotec.2011.12.012_bib0060 article-title: Inclusion bodies: formation and utilization publication-title: Adv. Biochem. Eng./Biotechnol. doi: 10.1007/b93995 – volume: 110 start-page: 29 year: 2001 ident: 10.1016/j.jbiotec.2011.12.012_bib0070 article-title: Hypertension syndrome and cardiovascular events publication-title: Postgrad. Med. doi: 10.1080/00325481.2001.11445493 – year: 1989 ident: 10.1016/j.jbiotec.2011.12.012_bib0235 – volume: 53 start-page: 8106 year: 2005 ident: 10.1016/j.jbiotec.2011.12.012_bib0280 article-title: ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: a review publication-title: J. Agric. Food Chem. doi: 10.1021/jf0508908 – volume: 27 start-page: 1179 year: 2006 ident: 10.1016/j.jbiotec.2011.12.012_bib0200 article-title: Design of genetically modified soybean proglycinin A1aB1b with multiple copies of bioactive peptide sequences publication-title: Peptides doi: 10.1016/j.peptides.2005.11.007 – volume: 29 start-page: 1062 year: 2008 ident: 10.1016/j.jbiotec.2011.12.012_bib0095 article-title: The antihypertensive effect of peptides: a novel alternative to drugs? publication-title: Peptides doi: 10.1016/j.peptides.2008.02.005 – volume: 93 start-page: 437 year: 2010 ident: 10.1016/j.jbiotec.2011.12.012_bib0135 article-title: Physiological properties of bioactive peptides obtained from whey proteins publication-title: J. Dairy Sci. doi: 10.3168/jds.2009-2566 – volume: 55 start-page: 9380 year: 2007 ident: 10.1016/j.jbiotec.2011.12.012_bib0045 article-title: Optimizing angiotensin I-converting enzyme inhibitory activity of pacific hake (Merluccius productus) fillet hydrolysate using response surface methodology and ultrafiltration publication-title: J. Agric. Food Chem. doi: 10.1021/jf0713354 – volume: 17 start-page: 33 year: 2007 ident: 10.1016/j.jbiotec.2011.12.012_bib0205 article-title: Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis publication-title: Int. Dairy J. doi: 10.1016/j.idairyj.2005.12.011 – volume: 22 start-page: 1399 year: 2004 ident: 10.1016/j.jbiotec.2011.12.012_bib0020 article-title: Recombinant protein folding and misfolding in Escherichia coli publication-title: Nat. Biotechnol. doi: 10.1038/nbt1029 – volume: 28 start-page: 545 year: 2005 ident: 10.1016/j.jbiotec.2011.12.012_bib0150 article-title: Antiproliferative action of an angiotensin I-converting enzyme inhibitory peptide, Val-Tyr, via an L-type Ca2+ channel inhibition in cultured vascular smooth muscle cells publication-title: Hypertens. Res. doi: 10.1291/hypres.28.545 – volume: 54 start-page: 4568 year: 2006 ident: 10.1016/j.jbiotec.2011.12.012_bib0140 article-title: Angiotensin I-cornverting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max) publication-title: J. Agric. Food Chem. doi: 10.1021/jf060264q – volume: 103 start-page: 241 year: 2009 ident: 10.1016/j.jbiotec.2011.12.012_bib0220 article-title: Bioproduction and characterization of a pH responsive self-assembling peptide publication-title: Biotechnol. Bioeng. doi: 10.1002/bit.22274 – volume: 108 start-page: 335 year: 2004 ident: 10.1016/j.jbiotec.2011.12.012_bib0215 article-title: Accumulation, assemb1y, and digestibility of amarantin expressed in transgenic tropical maize publication-title: Theor. Appl. Genet. doi: 10.1007/s00122-003-1430-x – volume: 2 start-page: 181 year: 1987 ident: 10.1016/j.jbiotec.2011.12.012_bib0260 article-title: The effect of organic nitrogen and glucose on the production of recombinant human insulin-like growth factor in high cell density E. coli fermentations publication-title: J. Ind. Microbiol. Biotechnol. – volume: 94 start-page: 84 year: 2005 ident: 10.1016/j.jbiotec.2011.12.012_bib0160 article-title: Antihypertensive effect of casein hydrolisate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension publication-title: Br. J. Nutr. doi: 10.1079/BJN20051422 – volume: 13 start-page: 773 year: 2007 ident: 10.1016/j.jbiotec.2011.12.012_bib0175 article-title: Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production publication-title: Curr. Pharm. Des. doi: 10.2174/138161207780363068 – volume: 16 start-page: 61 year: 2006 ident: 10.1016/j.jbiotec.2011.12.012_bib0170 article-title: Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk publication-title: Int. Dairy J. doi: 10.1016/j.idairyj.2005.01.001 – volume: 78 start-page: 777 year: 1995 ident: 10.1016/j.jbiotec.2011.12.012_bib0190 article-title: Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk publication-title: J. Dairy Sci. doi: 10.3168/jds.S0022-0302(95)76689-9 – volume: 6 start-page: 527 year: 1995 ident: 10.1016/j.jbiotec.2011.12.012_bib0225 article-title: Advances in the use of Pichia pastoris for high-level gene expression publication-title: Curr. Opin. Biotechnol. doi: 10.1016/0958-1669(95)80087-5 – volume: 2 start-page: 403 year: 1990 ident: 10.1016/j.jbiotec.2011.12.012_bib0050 article-title: Effect of structural modifications on the assembly of a glycinin subunit publication-title: Plant Cell doi: 10.1105/tpc.2.5.403 – volume: 82 start-page: 886 year: 2002 ident: 10.1016/j.jbiotec.2011.12.012_bib0075 article-title: Characterisation of pseudocereal and cereal proteins by protein and amino acid analyses publication-title: J. Sci. Food Agric. doi: 10.1002/jsfa.1120 – volume: 148 start-page: 240 year: 2010 ident: 10.1016/j.jbiotec.2011.12.012_bib0130 article-title: Modification of the amaranth 11S globulin storage protein to produce an inhibitory peptide of the angiotensin I converting enzyme, and its expression in Escherichia coli publication-title: J. Biotechnol. doi: 10.1016/j.jbiotec.2010.06.009 |
SSID | ssj0004951 |
Score | 2.1353266 |
Snippet | ► We inserted 4 VY and 1 IPP antihypertensive peptides in the amarantin acidic subunit. ► Modified protein was overexpressed in Escherichia coli in a fermentor... Amaranth seeds are considered as an excellent complementary source of food protein due to their balanced amino acid composition. Amarantin acidic subunit has... |
SourceID | proquest pubmed crossref fao elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 59 |
SubjectTerms | 11S acidic subunit ACE inhibitory activity agitation air flow amaranth grain Amaranth seed Amaranthus - genetics amino acid composition Angiotensin-Converting Enzyme Inhibitors - isolation & purification Antihypertensive peptides Bioreactors culture media dietary protein environmental factors Escherichia coli Escherichia coli - genetics functional foods Gene Expression Regulation, Plant globulins hydrolysis oxygen peptides Peptides - chemistry peptidyl-dipeptidase A Plant Proteins - chemistry Plant Proteins - genetics Plant Proteins - isolation & purification protein synthesis Recombinant Proteins - genetics Recombinant Proteins - isolation & purification Seeds - genetics temperature |
Title | Overexpression of a modified protein from amaranth seed in Escherichia coli and effect of environmental conditions on the protein expression |
URI | https://dx.doi.org/10.1016/j.jbiotec.2011.12.012 https://www.ncbi.nlm.nih.gov/pubmed/22248593 https://www.proquest.com/docview/1686728862 https://www.proquest.com/docview/922497834 |
Volume | 158 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BvZQDakspoRQZiWt2117ndUQItG1VeoCVuFnjxKFZlQR1F4kTv6A_ujNxsguHFVKPieJHMuOZb5yZzwAnJWF2XYxy3teIQp3pOESSfYgZIsNVObZcnPzjMp5M9beb6GYDzvpaGE6r7Gy_t-mtte7uDLuvObyvquEVgZWUuWOY9CyOU64o1zphLR88rdI8KADwZxLGFC3R06sqnuFsMLMVkyF4Jk_eFZRqnX_aLLFZj0Jbb3TxDnY6GClO_Uzfw4arP8D2M3LBXfj7k7TUPXaJrrVoSoHirimqklCnaPkZqlpweYnAOySXtfgl5uTLBN09n7MsK86DFqQplcC6ED71g_t5Vh1Hk6CIuvCJX4KGIUC57Hw1-keYXpxfn03C7uyFMNdKLkKktZ5qN2orWcmDqSzi8ExqqRyBJp0UaNPMYpIVFkd2rKyTqPOoyPIk1nY83oOtuqndPgi0UkeOq6fR6lEpbZTkhMpK51oAlAWg-y9u8o6YnM_H-G36DLSZ6QRlWFBGKkOCCmCwbHbvmTlea5D24jQvVMyQ93it6T6J3-AtGV4zvVK8TcTcZGTuAzjudcLQyuTfLVi75mFuSOPiRKUUMgYg1jyTEYLizTcdwCevT8t3IeCmmYzu4P-n_Rne0pXyJZSHsLX48-C-EIZa2KN2kRzBm9Ov3yeX_wByDxn- |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB3Bcmh7qOgnobR1pV7Drr3Oh48IgZYC2wOsxM2yE6fNqiSou0j9Ef3RzMTOLj2skHpN4sTJjGeenXnPAF8rxOyyHBW0rpHEUsk0Nmj72ChjCK7ysSVy8uU0nczkt5vkZguOey4MlVWG2O9jehetw5Fh-JrDu7oeXiFYyUk7hkTP0jTPtmGH1KmSAewcnZ1Ppmt6pEr8toQpTpiwwZrIM5wfzm1NeghezJMWBrnYlKK2K9NuBqJdQjrdhZcBSbIj39lXsOWa1_Dikb7gG_j7HR3V_Qm1rg1rK2bYbVvWFQJP1kk01A0jhgkztwaz1vInW2A6Y3j0ZEHmrKkUmqGz1Mw0JfPVH3SfRwQ57AROqktf-8XwMYgpVzdfP_0tzE5Pro8ncdh-IS6k4MvY4HDPpRt1ZFZMYkIlNEPjkguHuElmpbG5siZTpTUjOxbWcSOLpFRFlko7Hr-DQdM2bg-YsVwmjgjUxspRxW2SFQjMKuc6DKQikP0X10XQJqctMn7pvghtroOhNBlKc6HRUBEcrprdeXGOpxrkvTn1P16mMYE81XQPza_ND4y9enYlaKWI5Mkw4kfwpfcJjYOT_riYxrX3C40el2Yix1ljBGzDNQpBFK2_yQjee39avQtiN0l6dPv_3-3P8GxyfXmhL86m5x_gOZ4RnlF5AIPl73v3ESHV0n4KQ-YBC-scrw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overexpression+of+a+modified+protein+from+amaranth+seed+in+Escherichia+coli+and+effect+of+environmental+conditions+on+the+protein+expression&rft.jtitle=Journal+of+biotechnology&rft.au=Castro-Mart%C3%ADnez%2C+Claudia&rft.au=Luna-Su%C3%A1rez%2C+Silvia&rft.au=Paredes-L%C3%B3pez%2C+Octavio&rft.date=2012-03-31&rft.pub=Elsevier+B.V&rft.issn=0168-1656&rft.volume=158&rft.issue=1-2&rft.spage=59&rft.epage=67&rft_id=info:doi/10.1016%2Fj.jbiotec.2011.12.012&rft.externalDocID=US201500164219 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-1656&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-1656&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-1656&client=summon |